What we know A new Wisconsin bill, AB2, calls for school districts to ban them during class time, but there would be exceptions. First, this proposal has to work its way through the Wisconsin ...

AB2 Bio has made an option and licencing agreement with Nippon Shinyaku, granting the latter the option to obtain exclusive rights to commercialise Tadekinig alfa in the US. This therapy treats a ...